The paper describes a new, simple, selective and precise high-performance thin-layer chromatographic (HPTLC) method for the simultaneous identification and quantitative determination of boric acid (BA) and calcium fructoborate (CFB) in bulk and tablet/capsule dosage forms of dietary supplements. HPTLC silica gel G 60 F254 precoated glass plates were used as the stationary phase. The mobile phase consisted of 2-propanol-water 8:2 (v/v). The two boron-based compounds were adequately separated with the Rf values of 0.83 ± 0.01 (BA) and 0.59 ± 0.01 (CFB).
Introduction
Boron can be found in plant material as borate monoesters and diesters along with boric acid (BA). [1] [2] [3] [4] The bis-fructose ester of BA has been detected in plants, fruits, seeds, honey, and some foodstuffs; it is clear that the fructoborate ester is a naturally occurring part of the human diet. 5, 6 Calcium fructoborate (CFB), a natural sugar-borate ester, is the most studied boronbased compound and the only nutritional supplement that is found in nature. [7] [8] [9] CFB is a patented plant mineral compound, which is displayed and sold as bulk as a nutritional supplement under the name of FruiteX-B ® (FrxB), 10 a nature-identical analogue of a plant mineral complex with potential health benefits for conditions associated with inflammation of the bone, joint and cardiovascular system. [6] [7] [8] [9] [10] [11] [12] In the past, quantification of boronic/boric/borate esters has been performed using liquid and solid 11 B-NMR, 11,13,14 TLC, [15] [16] [17] HPLC coupled with UV or fluorometric detection, 18 thermal analysis, X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), Raman and inductively coupled plasma (ICP) spectroscopy 19 either alone or in combination with other compounds.
To the extent of our knowledge, no articles linked to the simultaneous HPTLC quantitation of BA and CFB in dietary supplement dosage forms have been reported in literature. The thermal analysis of FrxB shows that it is similar to the CFB found in natural products, as a unique entity, calcium fructoborate diester (Fig. 1) . The molecular formula of calcium fructoborate diester has been identified to be Ca[(C6H10O6)2B]2·4H2O. 19 In this paper, we describe a new, simple, fast, precise and specific HPTLC-densitometric analysis for the simultaneous quantitation of BA and CFB in bulk and tablets/capsules of dietary supplements. Recently, we have used this method for the estimation and validation of total boron and CFB in some foodstuffs.
Experimental

Reagents and chemicals
FruiteX-B ® and CFB standard (synthesized according to Hunter's US Patent) 10 were provided by VDF FutureCeuticals (Momence, IL). The purity of CFB (2.7%, expressed in boron) was provided by multinuclear magnetic resonance (mNMR) using liquid and solid state 11 B-and 13 C-NMR. [13] [14] [15] Borax (sodium tetraborate decahydrate), Optibor ® (boric acid) and four different boron-dietary supplement products (A -D, containing commercial CFB) were purchased from local (Romanian and USA) diet food stores. The BA for standards was obtained commercially from Merck Millipore (Table S1 , Supporting Information).
The chromatographic grade solvents and reagents, such as 2-propanol, ethanol (99%) and water (LiChrosolv ® ) were purchased from Merck (Darmstadt, Germany), and the chlorogenic acid from Sigma-Aldrich (Munich, Germany).
Preparation of standard and sample solutions
For the standards, a stock solution of BA was prepared by solubilizing 25 mg in 25 mL of water (0.1% concentration). The standard stock solution for CFB was prepared by solubilizing 125 mg in 25 mL of water (0.5% concentration). The standard working solutions were obtained by diluting the stock solution with water in order to achieve the concentration range 0.2 -0.8 μg/band for BA and 1 -4 μg/band for CFB (Table S2 , Supporting Information). One microliter of each standard solution was applied on the HPTLC plate. Each concentration was spotted three times (n = 3) on the HPTLC plate.
Each of the analyzed products had BA or CFB in different concentrations (Table S3 , Supporting Information). For dosage forms, the content of 20 tablets/capsules was finely powdered and the mean weight was determined. The bulk products, used as such, were also finely powdered and weighed. Considering the label claim, the amounts of BA or CFB were established to fit the linearity range (Tables S2 and S3 , Supporting Information).
Equipment
For the quantitative evaluation and sample application, a CAMAG TLC Scanner III and Linomat V (CAMAG, Muttenz, Switzerland) connected with a computer system and winCATS software (WinCATS Ver. 1.4.3) were used. A CAMAG UV cabinet was used for visualization. The images were acquired with a Nikon Coolpix S8000 digital camera of 14.2 million effective pixels' resolution and 10× optical zoom (Nikon Instruments Europe B.V.). Bandelin Sonorex Super ultrasonic bath (Bandelin Electronic GmbH & Co. KG, Berlin, Germany) and Eppendorf 5804 centrifuge (Eppendorf, Hamburg, Germany) were also used for the sample preparation.
HPTLC analysis
The analysis was performed on HPTLC silica gel G 60 F254 glass plates (20 × 10 cm, Merck DC). Application of standard and sample solutions was achieved using the semiautomatic TLC sample spray band applicator (CAMAG Linomat V). The composition of the mobile phase for the HPTLC method was optimized by testing various solvent combinations of distinct polarities: e.g., ethanol-water (9:1 and 8:2, v/v), methanolethanol-water (4.5:4.5:1, v/v/v), n-butanol-acetic acid-water (4:1:5, v/v/v), ethanol-chloroform-n-butanol-25% ammonia (5:2:4:1, v/v/v/v), chloroform-methanol-water-ammonium hydroxide (120:75:6:2, v/v/v/v). The optimum result was obtained by using 2-propanol-water (8:2, v/v, pH 7.53). The plate was sprayed densely and uniformly with 0.1% chlorogenic acid ethanolic solution, dried with an air dryer for ca. 1 min, and then visualized at 365 nm. 15, 16 The quantification analysis of the samples was achieved with the aid of the CAMAG TLC Scanner III. The selected mobile phase offered a good resolution with a retention (Rf) value of 0.83 ± 0.01 for BA and of 0.59 ± 0.01 for CFB. Due to its complete hydrolysis, during the elution process on the HPTLC plate, borax was identified only as BA. 20 The method was used to determine and differentiate BA of CFB content in various dietary supplement products (bulk, tablets and capsules) (Figs. 2 and 3 ).
Results and Discussion
Validation of the method
The validation process for the optimized HPTLC assay was realized in terms of the following criteria: specificity, linearity and range, precision, accuracy, limit of detection (LOD) and limit of quantification (LOQ), and finally, ruggedness and robustness.
The specificity was assessed through the purity of the BA and CFB peaks, using WinCATS Ver. 1.4.3 software package, by comparing the spectra at peak start, peak apex, and peak end positions of the band. A good correlation (r 2 = 0.9996) was also obtained between standard and sample (dietary supplement products A -D, FruiteX-B ® ) spectra of CFB. Using 2-propanolwater (8:2, v/v, pH 7.53) as the mobile phase, we established the method specificity for the UV fluorescent complex obtained from the boron-based compounds with the chlorogenic acid. The compounds that are not "UV active" do not absorb at the wavelength of 365 nm. The linearity of the method for BA and CFB quantitation was established between 0.2 -0.8 μg/band, and 1 -4 μg/band, respectively. The data of peak area versus concentration (Figs. S1 and S2, Supporting Information) were treated by linear regression (Table S2 , Supporting Information) and showed a good relationship over the mentioned concentration ranges (Table S3 , Supporting Information).
The precision, expressed in terms of %RSD (relative standard deviation), was assessed through the determination of the repeatability of sample application and measurement of peak area. The results reveal intra-and inter-day variation of BA and CFB at three different concentration levels of 0.2, 0.4 and 0.6 μg/band for BA and 1, 2 and 4 μg/band for CFB. The precision testing was sustained in triplicate (Table S4 , Supporting Information).
The accuracy was expressed as recovery through the method of standard addition. Pre-analyzed samples of BA (Optibor ® bulk, 0.2 μg/band) and CFB (FruiteX-B ® bulk, 1 μg/band) were adjusted with additional BA and CFB standards (0, 50, 100 and 150%) and the new samples were reanalyzed. After spiking with 50, 100 and 150% of additional standards, the provided recovery was 98 -102% (Table S5 , Supporting Information).
LOD and LOQ were calculated to be 0.05 and 0.16 μg/band for BA, and 0.27 and 0.83 μg/band for CFB, respectively.
The ruggedness of the proposed HPTLC method was carried out in two separate laboratories, with distinct analysts, instruments, batches of reagents and analysis parameters. The laboratories were the Laboratory of Pharmacognosy & Phytotherapy, University of Medicine and Pharmacy of Craiova (Romania) and the Laboratory of VDF FutureCeuticals (USA). The robustness of the method was tested for minor changes in the composition of the mobile phase, for different saturation times and migration distances. Also, %RSD was found to be less than 2% (Tables S6 -S9 , Supporting Information).
Analysis of dosage forms and bulk products
On the HPTLC chromatogram, BA and CFB exhibited single and distinctive bands (Rf is 0.83 and 0.59, respectively) (Figs. 2  and 3 ). The study revealed that the presence of other active compounds and excipients do not interfere in the quantitation of CFB. The low %RSD values (Tables S4 -S9 , Supporting Information) indicated the suitability of this method for routine analysis of CFB in nutraceutical dosage forms.
